Back to GEODE CAPITAL MANAGEMENT, LLC GEODE CAPITAL MANAGEMENT, LLC

DNTHDNTH
12 quarters

Position history for GEODE CAPITAL MANAGEMENT, LLCGEODE CAPITAL MANAGEMENT, LLC's holdings in Dianthus Therapeutics, Inc.

GEODE CAPITAL MANAGEMENT, LLC holds 1.3M shares of DNTH (Dianthus Therapeutics, Inc.), worth $122.7M as of 2026-Q2. The position was increased (+37.4% shares). DNTH represents 0.0% of GEODE CAPITAL MANAGEMENT, LLC's portfolio.

Current Value

$122.7M

Current Shares

1.3M

Total Value Change

+$122.3M

Total Shares Change

+1.2M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
1.3M
+37.4%
$122.7M0.0%$97.48
39
2026-Q1
Increased
916,211
+35.4%
$76.9M0.0%$55.39
39
2025-Q4
Increased
676,658
+26.1%
$27.9M0.0%$40.96
35
2025-Q3
Increased
536,415
+10.6%
$21.1M0.0%$39.55
31
2025-Q2
Decreased
484,900
-6.2%
$9M0.0%$17.63
0
2025-Q1
Increased
517,018
+6.3%
$9.4M0.0%$19.99
29
2024-Q4
Increased
486,263
+0.2%
$10.6M0.0%$21.50
28
2024-Q3
Decreased
485,121
-2.8%
$13.3M0.0%$27.24
0
2024-Q2
Increased
498,920
+570.6%
$12.9M0.0%$25.88
45
2024-Q1
Increased
74,400
+64.7%
$2.2M0.0%$30.00
38
2023-Q4
Increased
45,179
+71.5%
$469,9350.0%$10.40
24
2023-Q3
New
26,341
-
$360,1890.0%$13.67
36

Other major holders of DNTH: FMR LLC, BlackRock, Inc., WELLINGTON MANAGEMENT GROUP LLP

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used